FDA Offers Advice on Safe Dosing Practices for Diabetes Medications

FDA Offers Advice on Safe Dosing Practices for Diabetes Medications

The U.S. Food and Drug Administration (FDA) has issued a warning to both patients and healthcare providers regarding dosing errors associated with compounded versions, NOT the genuine manufactured product, of Novo Nordisk’s weight-loss and diabetes drugs,...
Mounjaro Takes the Lead Over Ozempic

Mounjaro Takes the Lead Over Ozempic

A new study reveals that Eli Lilly’s Mounjaro significantly outperforms Novo Nordisk’s Ozempic in promoting weight loss, despite both drugs sharing similar side effects and dropout rates.Key FindingsThe research, published in JAMA Internal Medicine,...
Facebook
Instagram